Safety biomarkers segment is expected to account for the largest share of Global Biomarkers Market – Analysis and Forecast 2014 – 2022 - A new report by Data Bridge Market Research.

Global Biomarkers Market Trends and Forecast to 2022 - By Product Type (Consumables, Services), By Technology (Predictive, Pharmacodynamic, Safety), Application (Diagnostics, Drug Discovery, Personalized Medicine), Indication (Cardiovascular, Immunological) By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa)

Access Full Report: http://databridgemarketresearch.com/reports/global-biomarkers-market/ 

Biomarkers are substances or activities that serve as markers of a specific biological activity. Biomarkers are extensively used in research and diagnostic applications. In addition to this, they are also used in the development of new drug therapies through the discovery of new target drugs. The global biomarkers market is expected to reach USD 62.0 billion by 2022, at a CAGR of 12.1% from 2016 to 2020. Factors such as increasing healthcare expenditure, increase in R&D funding, rising utility of biomarkers for diagnostic purposes, growing number of CROs, low-cost for conducting clinical trials in developing countries, and new initiatives for biomarker research are driving the growth of the biomarkers market. On the other hand, high capital investments and high cost-to-benefit ratio; regulatory and reimbursement challenges; and high cost of testing, sample collection, and storage are the major factors restraining the growth of this market.

Data Bridge Market Research is providing a release offer to the first few clients a discount of 10% on this report, additionally 30 days of free customization is also included in this report. In case of requirement a presentation can also be bundled with this report including important graphs and charts. Procedure and patient data is also available though it may incur some additional charges.